Key Insights

Highlights

Success Rate

95% trial completion (above average)

Published Results

13 trials with published results (6%)

Research Maturity

79 completed trials (35% of total)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

1.8%

4 terminated out of 223 trials

Success Rate

95.2%

+8.7% vs benchmark

Late-Stage Pipeline

13%

30 trials in Phase 3/4

Results Transparency

16%

13 of 79 completed with results

Key Signals

13 with results95% success

Data Visualizations

Phase Distribution

185Total
Not Applicable (103)
P 1 (32)
P 2 (20)
P 3 (16)
P 4 (14)

Trial Status

Completed79
Recruiting61
Not Yet Recruiting41
Active Not Recruiting29
Terminated4
Withdrawn3

Trial Success Rate

95.2%

Benchmark: 86.5%

Based on 79 completed trials

Clinical Trials (223)

Showing 20 of 20 trials
NCT06845202Phase 1Recruiting

A Study to Evaluate ALN-4324 in Overweight to Obese Healthy Volunteers and in Overweight to Obese Patients With T2DM

NCT06897202Phase 2Completed

A Study to Evaluate the Efficacy and Safety of Once-Weekly MET097 in Adults With Obesity or Overweight and T2DM

NCT07465224Phase 2RecruitingPrimary

A Study to Evaluate ALN-4324 on Insulin Sensitivity in Adults With Type 2 Diabetes Mellitus

NCT07255222Not ApplicableActive Not RecruitingPrimary

Effects of a Multimodal Exercise Program on Physical Performance and Muscle Function in Middle-aged Patients With T2DM

NCT07387393Not ApplicableEnrolling By Invitation

To Test the Effectiveness and Implementation Approach of a 3-month PILI Pasifika Program Lifestyle Program With Components of Social Determinants of Health Activities in Real-world Settings (Clinical and Non-clinical Settings) Across 3 Years

NCT07632677RecruitingPrimary

Diagnostic Value of the Liver Inflammation Index for MASH in Patients With T2DM and MAFLD

NCT07604922Not ApplicableNot Yet Recruiting

Investigating Vascular Properties of HEMI and SPG Signals in Individuals With or at Risk for Chronic Kidney Disease

NCT06887049Not ApplicableRecruitingPrimary

Achieving Routine Intervention and Screening for Emotional Health

NCT07628985Phase 3Not Yet RecruitingPrimary

BALANCE-DM2 Study of Bofanglutide in Adults With Type 2 Diabetes

NCT07630233Phase 1Not Yet RecruitingPrimary

A Phase I Study of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Single Subcutaneous UBT38006 Injection in Healthy Adult Males

NCT07617766Not ApplicableNot Yet RecruitingPrimary

Mindfulness Training in Type 2 Diabetes

NCT07614230Phase 4RecruitingPrimary

SGLT2 Inhibitors on Coronary Atherosclerosis Progression Via Perivascular Adipose Tissue in Diabetes

NCT06888687Not ApplicableActive Not RecruitingPrimary

Comparison of Dietetics Support With and Without Continuous Glucose Monitoring in Individuals With Type 2 Diabetes.

NCT07463209Not ApplicableNot Yet Recruiting

Integrating New Skills Into Diabetes Education With CGM

NCT07433257Recruiting

The Effect of Local Corticosteroid Injection in Carpal Tunnel Syndrome Patients With Type 2 Diabetes

NCT07606872Not ApplicableNot Yet RecruitingPrimary

Validation of the Snouda Metabolic Score for Phenotyping and Guiding Reversal in Type 2 Diabetes

NCT06613711Not ApplicableCompleted

MagDI Italian Study

NCT07005362Recruiting

Fitbit and AI Chatbot in Sedentary Primary Care Patients With T2D

NCT07167004Not ApplicableRecruiting

The GRoceries Aimed at Increasing Nutrition Study

NCT07595289Not ApplicableNot Yet RecruitingPrimary

DP-DCT 1.0:A Comparative Clinical Study on the Effect of Dapagliflozin Combined With CGM Versus SMBG on Glycemic Control in Patients With Type 2 Diabetes Mellitus Based on the DP-DCT Platform

Scroll to load more

Research Network

Activity Timeline